18.70 USD
↘ 0.00 (0.01%)PRE MARKET (AS OF 08:54 AM EDT)
Avalo Therapeutics, Inc. Common Stock
AVTXNASDAQ • USD
Market: OPEN
Shares of Avalo Therapeutics, Inc. Common Stock (AVTX) are trading at $18.70. AVTX shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 6, 2026.
Open?$18.49
High?$18.87
Low?$18.47
Prev. Close?$18.70
Volume?3.2K
Avg. Volume?1.3M
VWAP?$18.54
Rel. Volume?0.00x
Bid / Ask
Bid?$15.05 × 100
Ask?$22.70 × 100
Spread?$7.65
Midpoint?$18.88
Valuation & Ratios
Market Cap?1.0B
Shares Out?52.9M
Float?21.2M
Float %?86.6%
P/E Ratio?N/A
P/B Ratio?14.68
EPS?-$1.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Employees
33
Market Cap
996.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
WAYNE, PA 19087
Phone: 410-522-8707
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?10.81Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?59.74%Squeeze Risk
Short Interest?12.7M
Days to Cover?10.7
Free Float21.2M
Avg Daily Volume1.2M
Settlement Date2026-07-15
Financial Health
Current Ratio?7.66Strong
Quick Ratio?7.66Strong
Cash Ratio?2.15Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?14.68HIGH▾
Peers100
S&P12
P/S?16,997.98HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-12.4CHEAP▾
S&P97
EV/Sales?16,574.45HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-124.0%WEAK▾
S&P3
ROA?-84.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$977.9M
Fundamentals ratios updated end of day